Integrating Prime Editing and Cellular Reprogramming as Novel Strategies for Genetic Cardiac Disease Modeling and Treatment
Open Access
- 11 September 2024
- journal article
- research article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 26 (11) , 1197-1208
Abstract
Purpose of review: This review aims to evaluate the potential of CRISPR-based gene editing tools, particularly prime editors (PE), in treating genetic cardiac diseases. It seeks to answer how these tools can overcome current therapeutic limitations and explore the synergy between PE and induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for personalized medicine. Recent findings: Recent advancements in CRISPR technology, including CRISPR-Cas9, base editors, and PE, have demonstrated precise genome correction capabilities. Notably, PE has shown exceptional precision in correcting genetic mutations. Combining PE with iPSC-CMs has emerged as a robust platform for disease modeling and developing innovative treatments for genetic cardiac diseases. Summary: The review finds that PE, when combined with iPSC-CMs, holds significant promise for treating genetic cardiac diseases by addressing their root causes. This approach could revolutionize personalized medicine, offering more effective and precise treatments. Future research should focus on refining these technologies and their clinical applications.Keywords
Funding Information
- European Research Council (H2020-EVICARE (#725229))
- NWO-TTP HARVEY (2021/TTW/01038252)
- Chinese Scholarship Council (202006170055)
This publication has 100 references indexed in Scilit:
- Genome engineering using the CRISPR-Cas9 systemNature Protocols, 2013
- Induced Pluripotent Stem Cells (iPSCs) Derived from Different Cell Sources and their Potential for Regenerative and Personalized MedicineCurrent Molecular Medicine, 2013
- Genetics of Human Cardiovascular DiseaseCell, 2012
- Vascular dysfunction in idiopathic dilated cardiomyopathyNature Reviews Cardiology, 2009
- Adeno-Associated Virus (AAV) Serotype 9 Provides Global Cardiac Gene Transfer Superior to AAV1, AAV6, AAV7, and AAV8 in the Mouse and RatHuman Gene Therapy, 2008
- Induction of pluripotent stem cells from mouse fibroblasts by four transcription factorsCell Proliferation, 2007
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- CRISPR Provides Acquired Resistance Against Viruses in ProkaryotesScience, 2007
- Long QT syndrome: reduced repolarization reserve and the genetic linkJournal of Internal Medicine, 2005
- Phenotypic diversity in hypertrophic cardiomyopathyHuman Molecular Genetics, 2002